Atlantic Therapeutics Funding: $60M Raised, Series C (2021)
Atlantic Therapeutics is based in Galway, Ireland. It has raised $60M in total funding. Latest round: Series C.
Atlantic Therapeutics funding overview
Atlantic Therapeutics is based in Galway, Ireland. Atlantic Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2021. The round record for Atlantic Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include LSP, Andera Partners, Atlantic Bridge Ventures, Earlybird, Seroba Life Sciences, Borski Fund and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Atlantic Therapeutics funding
How much has Atlantic Therapeutics raised?
Atlantic Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Atlantic Therapeutics?
LSP, Andera Partners, Atlantic Bridge Ventures, Earlybird, Seroba Life Sciences, Borski Fund are named among the investors backing Atlantic Therapeutics.
What was the latest Atlantic Therapeutics funding round?
The most recent disclosed round is a Series C, announced in June 2021.
Where is Atlantic Therapeutics based?
Atlantic Therapeutics is based in Galway, Ireland.
When did Atlantic Therapeutics last raise?
The last disclosed Atlantic Therapeutics round closed in June 2021 at Series C.
Atlantic Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Galway below to benchmark round size and investor mix.
